No defined host molecular drug target

The designation "No defined host molecular drug target" is used in pharmacology to classify therapeutic agents that do not exert their effects by binding to a specific biological macromolecule, such as a receptor, enzyme, or transporter (DrugBank, 2024). Instead, these drugs function through direct chemical or physical interactions within the body. For example, antacids like aluminum hydroxide neutralize gastric acid through simple stoichiometry, while osmotic laxatives like polyethylene glycol alter fluid dynamics in the intestinal lumen to promote bowel movements (StatPearls, 2023). Other agents in this category include adsorbents like activated charcoal, which physically binds toxins to prevent their absorption, and chelating agents that sequester heavy metals (NIH, 2023). Because these agents lack a specific protein target, their pharmacodynamics are governed by their physical properties or chemical reactivity rather than target affinity or intracellular signaling cascades. This classification is essential for distinguishing between targeted molecular therapies and treatments with broad, non-specific modes of action (FDA, 2023).

Other names

Non-molecular targetNon-specific mechanism of actionPhysical/Chemical mechanismNon-protein target

Drugs in this category act via non-specific chemical or physical mechanisms, such as acid-base neutralization, osmotic gradient formation, physical adsorption of toxins, or chemical chelation of metal ions, rather than binding to a specific protein or nucleic acid target (DrugBank, 2024; StatPearls, 2023).